ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IS ASSOCIATED WITH MYOCARDIAL-INFARCTION BUT NOT WITH DEVELOPMENT OF CORONARY STENOSIS

被引:190
|
作者
LUDWIG, E
CORNELI, PS
ANDERSON, JL
MARSHALL, HW
LALOUEL, JM
WARD, RH
机构
[1] UNIV UTAH,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112
[3] UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112
[4] LATTER DAY ST HOSP,DIV CARDIOL,SALT LAKE CITY,UT
关键词
BRIEF COMMUNICATION; MYOCARDIAL INFARCTION; GENES; CORONARY DISEASE; ANGIOTENSIN;
D O I
10.1161/01.CIR.91.8.2120
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although both genetic and nongenetic factors contribute to the pathogenesis of coronary artery disease, the identification of specific genetic lesions has lagged behind the identification of critical environmental risk factors. A reported association between myocardial infarction (MI) and the insertion/deletion (I/D) polymorphism of the angiotensin-convert ing enzyme (ACE) gene in European men suggests a critical role for this genomic region. However, the generality of this association remains to be determined. It also is not clear at what stage in disease progression the association with the ACE I/D polymorphism becomes important. Methods and Results We evaluated the ACE IID polymorphism in patients who had undergone coronary angiography (402 men and 295 women) and in 203 representative control subjects. After polymerase chain reaction amplification, genotypes were determined by agarose gel sizing and by hybridization with allele-specific oligonucleotides. After patients were categorized by the degree of coronary artery stenosis and the occurrence of an MI, the distribution of ACE I/D genotypes was evaluated by log linear analysis. Patients were genetically representative of the regional population, and patients with >60% stenosis of their coronary arteries had the same distribution of ACE I/D genotypes as did patients with <10% stenosis. However, among patients with stenosis, the occurrence of an MI was significantly associated with the D allele in all patients (odds ratio [OR], 1.59; P=.002) and in men alone (OR, 1.63; P=.006). The lack of significance in women (OR, 1.40; P=.263) is probably due to the fact that only 36 women in the present study had experienced an MI. Furthermore, the association between MI and the ACE I/D polymorphism was independent of blood pressure, smoking habits, and body mass index. Conclusions Segregation of the ACE I/D polymorphism is a pervasive genetic risk factor for MI in whites but has no evident effect on the events leading to stenosis of the coronary arteries. This suggests that risk of MI is influenced by two independent processes-atherogenesis that leads to coronary stenosis followed by conversion to MI. The renin-angiotensin system appears to confer significant risk of infarction by influencing the conversion to MI but has no apparent effect on the development of atherostenosis.
引用
收藏
页码:2120 / 2124
页数:5
相关论文
共 50 条
  • [31] Predictors of coronary in-stent restenosis:: Importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors
    Jorgensen, E
    Kelbæk, H
    Helqvist, S
    Jensen, GVH
    Saunamäki, K
    Kastrup, J
    Havndrup, O
    Bundgaard, H
    Madsen, JK
    Christiansen, M
    Andersen, PS
    Reiber, JHC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) : 1434 - 1439
  • [32] CARDIAC ANGIOTENSIN-CONVERTING ENZYME ACTIVATION IS AN EARLY RESPONSE TO EXPERIMENTAL MYOCARDIAL-INFARCTION
    HIRSCH, AT
    MUELLERLEILE, MR
    CARLYLE, WC
    LUNZER, MM
    DIZON, FD
    JUDD, D
    CLINICAL RESEARCH, 1994, 42 (03): : A391 - A391
  • [33] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AFTER MYOCARDIAL-INFARCTION - INDICATIONS AND TIMING
    BALL, SG
    HALL, AS
    MURRAY, GD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (07) : S42 - S46
  • [34] EARLY AND LATE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ACUTE MYOCARDIAL-INFARCTION
    BORGHI, C
    BACCHELLI, S
    ESPOSTI, DD
    AMBROSIONI, E
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (19): : G169 - G174
  • [35] Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in a Tunisian Healthy and Acute Myocardial Infarction Population
    Mehri, Sounira
    Baudin, Bruno
    Mahjoub, Sinda
    Zaroui, Amira
    Beneteau-Burnat, Benedicte
    Mechmeche, Rachid
    Hammami, Mohamed
    Ben Arab, Saida
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2010, 14 (01) : 85 - 91
  • [36] THE USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AFTER ACUTE MYOCARDIAL-INFARCTION
    MEHRA, IV
    WILSON, MD
    PHARMACOTHERAPY, 1993, 13 (05): : 440 - 446
  • [37] ACTIVATION OF ANGIOTENSIN-CONVERTING ENZYME EXPRESSION IN INFARCT ZONE FOLLOWING MYOCARDIAL-INFARCTION
    PASSIER, RCJJ
    SMITS, JFM
    VERLUYTEN, MJA
    STUDER, R
    DREXLER, H
    DAEMEN, MJAP
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (04): : H1268 - H1276
  • [38] COMPARISON OF ANGIOTENSIN-CONVERTING ENZYME AND RENIN INHIBITION IN RATS FOLLOWING MYOCARDIAL-INFARCTION
    MENTO, PF
    MAITA, ME
    MURPHY, WR
    HOLT, WF
    WILKES, BM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (05) : 791 - 796
  • [39] ASSOCIATION OF PLASMA ANGIOTENSIN-CONVERTING ENZYME ACTIVITY AND GENE POLYMORPHISM IN TUNISIAN PATIENTS AFFECTEDWITH MYOCARDIAL INFARCTION
    Mehri, S.
    Baudin, B.
    Mahjoub, C.
    Guemira, F.
    Rachid, M.
    Beneteau-Burnat, B.
    Ben Arab, S.
    Hammami, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 106 - 106
  • [40] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR USE IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION
    YIM, JM
    HOON, TJ
    BITTAR, N
    BAUMAN, JL
    BROWN, EJ
    CELESTIN, C
    PHILLIPS, BG
    VLASSES, PH
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16): : 1184 - 1186